Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,024Revenue $M276Net Margin (%)-8.9Z-Score16.5
Enterprise Value $M919EPS $-0.8Operating Margin %-8.6F-Score4
P/E(ttm))0Cash Flow Per Share $0.5Pre-tax Margin (%)-8.8Higher ROA y-yN
Price/Book6.610-y EBITDA Growth Rate %0Quick Ratio4.3Cash flow > EarningsY
Price/Sales3.55-y EBITDA Growth Rate %0Current Ratio4.3Lower Leverage y-yY
Price/Cash Flow54.0y-y EBITDA Growth Rate %-620.0ROA % (ttm)-13.8Higher Current Ratio y-yN
Dividend Yield %0Insider Buy (3m)0ROE % (ttm)-17.1Less Shares Outstanding y-yY
Payout Ratio %0Shares Outstanding M31.7ROI % (ttm)1.3Gross Margin Increase y-yN

Gurus Latest Trades with GHDX

Number of guru portfolios checked: 85. (List those with share number changes of more than 20%, or impact to portfolio more than 0.1%)
TickerGuruDate Action
Impactdown Price Range
(Average)*
Current Price Change from Average Comment Current Shares
GHDXDavid Swensen 2013-03-31 Sold Out -2.8%$26.72 - $29.65
($28.5)
$ 30.47%Sold Out0
GHDXDavid Swensen 2012-12-31 Buy 2.8%$26.42 - $36.8
($30.13)
$ 30.41%New holding, 37861 sh.37,861
GHDXDavid Swensen 2011-03-31 Sold Out -0.93%$21.08 - $26.18
($23.29)
$ 30.430%Sold Out0
GHDXDavid Swensen 2010-12-31 Buy 0.93%$13.18 - $23.52
($17.74)
$ 30.471%New holding, 38243 sh.38,243
GHDXGeorge Soros 2006-12-31 Sold Out -0.23%$13.85 - $23.89
($17.5)
$ 30.474%Sold Out0
GHDXGeorge Soros 2006-09-30 Buy 0.23%$11.16 - $14.38
($13)
$ 30.4134%New holding, 236371 sh.236,371
Premium Real Time Picks are included for Premium Members only!!
*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

GHDX is held by these Gurus:

Premium Most recent portfolio changes are included for Premium Members only!


GHDX: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Popovits Kimberly JPresident and CEO 2015-02-12Sell3,000$29.861.81view
Cole G BradleyCOO 2015-02-10Sell4,000$31.37-3.09view
LIVINGSTON RANDALL SDirector 2015-02-02Sell1,000$31.93-4.79view
Popovits Kimberly JPresident and CEO 2015-01-12Sell3,000$33.46-9.15view
Popovits Kimberly JPresident and CEO 2014-12-11Sell3,000$32.99-7.85view
Cole G BradleyCOO 2014-12-08Sell4,336$32.52-6.52view
Popovits Kimberly JPresident and CEO 2014-11-12Sell4,300$34.82-12.69view
Cole G BradleyCOO 2014-11-10Sell4,000$35.35-14view
LIVINGSTON RANDALL SDirector 2014-11-03Sell3,000$36.24-16.11view
Popovits Kimberly JPresident and CEO 2014-10-13Sell3,000$30.78-1.23view

Press Releases about GHDX :

    Quarterly/Annual Reports about GHDX:

    News about GHDX:

    Articles On GuruFocus.com
    CEO of InVitae Corporation of Genomic Health Inc. Randal W. Scott Sold 30,000 Shares Jul 13 2012 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Mar 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Mar 14 2011 
    Genomic Health Inc. (GHDX) COO G Bradley Cole sells 2,500 Shares Mar 10 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) CFO Dean L Schorno sells 1,000 Shares Feb 16 2011 
    Genomic Health Inc. (GHDX) Executive Chairman Randal W Scott sells 20,000 Shares Feb 14 2011 
    Genomic Health Inc. (GHDX) President and CEO Kimberly J Popovits sells 8,000 Shares Jan 19 2011 

    More From Other Websites
    GENOMIC HEALTH INC Files SEC form 8-K, Change in Directors or Principal Officers Feb 20 2015
    Genomic Health Announces Year-End 2014 Financial Results, Provides 2015 Financial Outlook Feb 16 2015
    Genomic Health Loss Narrower than Expected, Revenues Lag - Analyst Blog Feb 11 2015
    Genomic Health reports 4Q loss Feb 10 2015
    Genomic Health reports 4Q loss Feb 10 2015
    Genomic Health Inc Earnings Call scheduled for 4:30 pm ET today Feb 10 2015
    GENOMIC HEALTH INC Files SEC form 8-K, Results of Operations and Financial Condition, Financial... Feb 10 2015
    Genomic Health Announces Year-End 2014 Financial Results, Provides 2015 Financial Outlook Feb 10 2015
    Q4 2014 Genomic Health Inc Earnings Release - After Market Close Feb 10 2015
    Following NICE's Exclusive Recommendation, NHS England Agrees to Access Program for Oncotype DX®... Feb 05 2015
    Following NICE's Exclusive Recommendation, NHS England Agrees to Access Program for Oncotype DX®... Feb 05 2015
    Inivata Limited Announces New Board Member Patrick Terry Feb 05 2015
    Genomic Health to Announce Fourth Quarter and Year-End 2014 Financial Results and Host Conference... Feb 03 2015
    Should You Buy Genomic Health (GHDX) Ahead of Earnings? - Tale of the Tape Feb 02 2015
    GENOMIC HEALTH INC Files SEC form 8-K, Amendments to Articles of Inc. or Bylaws; Change in Fiscal... Jan 30 2015
    Genomic Health Plans Line of Liquid-Biopsy Tests for Cancer Jan 12 2015
    Genetic testing firm Invitae seeks IPO of $86 million (Video) Jan 09 2015
    Genomic Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 05 2015
    Genomic Health to Present at the 33rd Annual J.P. Morgan Healthcare Conference Jan 05 2015
    Claritas Genomics Appoints Patrick F. Terry as Chief Commercial Officer Dec 18 2014

    Add Notes, Comments

    If you want to ask a question, or report a bug, please create a support ticket.

    User Comments

    No comment yet
    Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
    GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
    Free 7-day Trial
    FEEDBACK